The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer.

OBJECTIVE This study examined the risk of antidepressant-induced manic switch in patients with bipolar disorder treated either with antidepressant monotherapy or with an antidepressant in conjunction with a mood stabilizer. METHOD Using Swedish national registries, the authors identified 3,240 patients with bipolar disorder who started treatment with an antidepressant and had no antidepressant treatment during the previous year. Patients were categorized into those receiving antidepressant monotherapy and those receiving an antidepressant plus a mood stabilizer. A within-individual design was used to control for confounding by disorder severity, genetic makeup, and early environmental factors. Cox regression analyses conditioned on individual were used to compare the rate of mania 0-3 months and 3-9 months after the start of antidepressant treatment with a preceding non-treatment period. RESULTS Nearly 35% of the patients were treated with antidepressant monotherapy. The increased risk of treatment-emergent mania was confined to patients on antidepressant monotherapy (hazard ratio=2.83, 95% CI=1.12, 7.19). Among patients treated with a concurrent mood stabilizer, no acute change in risk of mania was observed during the 3 months after the start of antidepressant treatment (hazard ratio=0.79, 95% CI=0.54, 1.15), and a decreased risk was observed during the period 3-9 months after treatment initiation (hazard ratio=0.63, 95% CI=0.42, 0.93). CONCLUSIONS In this national registry study, antidepressant monotherapy was associated with an increased risk of mania. However, no risk of mania was seen in patients receiving an antidepressant while treated with a mood stabilizer. The results highlight the importance of avoiding antidepressant monotherapy in the treatment of bipolar disorder.

• Publication year

  2014

• Venue

  American Journal of Psychiatry

• Publication date

  2014-10-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/appi.ajp.2014.13111501PMID 24935197
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

  2013cited by this paper
• Risk factors for antidepressant-related switch to mania.

  2012cited by this paper
• New treatment guidelines for acute bipolar depression: a systematic review.

  2011cited by this paper
• External review and validation of the Swedish national inpatient register

  2011cited by this paper
• Validity of bipolar disorder hospital discharge diagnoses: file review and multiple register linkage in Sweden

  2011cited by this paper
• Mania associated with antidepressant treatment: comprehensive meta‐analytic review

  2009cited by this paper
• The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research

  2009cited by this paper
• Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.

  2007cited by this paper
• Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder.

  2007cited by this paper
• The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six months

  2007cited by this paper
• Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

  2007cited by this paper
• Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers

  2007cited by this paper
• Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

  2006cited by this paper
• Bipolar depression: Diagnostic and treatment considerations

  2006cited by this paper
• Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.

  2005cited by this paper
• Bipolar disorder, antidepressants and induction of hypomania or mania. A systematic review

  2005cited by this paper
• Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review.

  2003cited by this paper
• A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder.

  2003cited by this paper
• Double-Blind Comparison of Addition of a Second Mood Stabilizer Versus an Antidepressant to an Initial Mood Stabilizer for Treatment of Patients With Bipolar Depression

  2003cited by this paper
• Antidepressant-induced mania: an overview of current controversies.

  2003cited by this paper
• The prognostic significance of "switching" in patients with bipolar disorder: a 10-year prospective follow-up study.

  2002cited by this paper
• The long-term natural history of the weekly symptomatic status of bipolar I disorder.

  2002cited by this paper
• Mood-stabilisers reduce the risk of developing antidepressant-induced maniform states in acute treatment of bipolar I depressed patients.

  2001cited by this paper
• Suicide attempts in bipolar patients.

  2001cited by this paper
• Antidepressant-induced mania in bipolar patients: identification of risk factors.

  2001cited by this paper
• Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression.

  2000cited by this paper
• Bipolar depression and antidepressant-induced mania: a naturalistic study.

  1998cited by this paper
• Antidepressant-induced mania and cycle acceleration: a controversy revisited.

  1995cited by this paper
• Induction of Mania with Selective Serotonin Re-uptake Inhibitors and Tricyclic Antidepressants

  1994cited by this paper
• Switch from depression to mania--a record study over decades between 1920 and 1982.

  1985cited by this paper
• The induction of mania. A natural history study with controls.

  1982cited by this paper
• Rapid cycling in manic-depressives induced by tricyclic antidepressants.

  1979cited by this paper
• Lithium carbonate and imipramine in prevention of affective episodes. A comparison in recurrent affective illness.

  1973cited by this paper
• The treatment of depressive states with impiramine hydrochloride.

  1960cited by this paper
• A Controlled Trial of Imipramine in Treatment of Depressive States

  1959cited by this paper
• The treatment of depressive states with imipramine hydrochloride (tofranil).

  1959cited by this paper

• Treatment challenges in a 25-year-old female with bipolar disorder and social phobia: A case study

  2026cites this paper
• Real-World Evidence for Psychiatric Disorders from the German Disease Analyzer Database: A Narrative Review

  2026cites this paper
• Antidepressant‐Associated Risk of Manic and Mixed Episode Hospitalization in Bipolar I Disorder: A 10‐Year Population‐Based Cohort Study

  2026cites this paper
• Transient Mood Elevation Without a Manic Switch: Goldenseal-Augmented Oral Glutamatergic Regimen in Bipolar Depression With Comorbid Obsessive-Compulsive Disorder (OCD).

  2026cites this paper
• The Swedish bipolar collection (SWEBIC)

  2025cites this paper
• Focus on mood disorders, obsessive-compulsive disorders, and prisoners' treatments.

  2025cites this paper
• Treatment of depressive episodes with mixed features: A systematic review and meta-analysis.

  2025cites this paper
• Length of hospital admission, cannabis use and associated factors in patients with bipolar disorder

  2025cites this paper
• Risk of Switch to Mania/Hypomania in Bipolar Depressive Patients Treated with Antidepressants: A Real-World Study

  2025cites this paper
• Identifying clinical markers of bipolar disorder in a depressed outpatient sample: A tertiary clinic comparison with major depressive disorder.

  2025cites this paper
• Antidepressant treatment and risk of subsequent bipolar disorder in adolescents with unipolar depression

  2025cites this paper
• Antidepressant Remission and Manic Switch in Bipolar Depression: A Propensity Score Analysis

  2025cites this paper
• Recommendations for defining treatment outcomes in major psychiatric disorders using real-world data.

  2025cites this paper
• Patterns and trends of medication use among patients with bipolar disorder in Northeast China: A study from a large psychiatric center (2013-2022).

  2025cites this paper
• The use of antidepressants for bipolar disorder - a controversy between science and clinical practice.

  2025cites this paper
• Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study.

  2025cites this paper
• Prescribing Patterns for the Treatment of Bipolar Disorder in Pregnancy: A Retrospective Cohort Study

  2025cites this paper
• Hospital-based care for hallucinogens and risk of mania and bipolar disorder: A population-based cohort study

  2025cites this paper
• Unraveling the connections between migraine and psychiatric comorbidities: A narrative review.

  2025cites this paper
• Diagnostic Conversion From Psychotic Unipolar Depression to Bipolar and Psychotic Disorders: A Swedish Registry‐Based Study

  2025cites this paper
• Uncovering predictors of bipolar II conversion to bipolar I: A machine learning analysis of national health records in Taiwan.

  2025cites this paper
• Real-world effectiveness of pharmacological maintenance treatment of bipolar depression: a within-subject analysis in a Swedish nationwide cohort.

  2025cites this paper
• Is Theta Burst Stimulation Ready as a Clinical Treatment for Bipolar Disorder?

  2025cites this paper
• Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data.

  2024cites this paper
• Predicting Diagnostic Conversion From Major Depressive Disorder to Bipolar Disorder: An EHR Based Study From Colombia

  2024cites this paper
• The prevalence and clinical correlates of suicide attempts in patients with bipolar disorder misdiagnosed with major depressive disorder: Results from a national survey in China.

  2024cites this paper
• Switching concerns: Bipolar disorder and the antidepressant dilemma

  2024cites this paper
• Pseudodementia in Patients with Unipolar and Bipolar Disorders: A Case Series and Literature Review

  2024cites this paper
• Bipolar disorder in the practice of family medicine

  2024cites this paper
• Distinguishing Affective Temperament Profiles in Major Depressive Disorder and Bipolar Disorder Through the Short Version of TEMPS-A: Cross-Sectional Study Using Latent Profile Analysis

  2024cites this paper
• The Association of Antidepressant Use and Impulse Control Disorder in Parkinson's Disease.

  2024cites this paper
• Cognitive behavioural therapy for social anxiety disorder in people with bipolar disorder: a case series

  2024cites this paper
• Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder

  2024cites this paper
• A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?

  2024cites this paper
• Question: Do You Have Suggestions for Managing a Patient With Bipolar II Disorder, Binge Eating Disorder, and Obesity Who Stops Medications Fearing Weight Gain?

  2024cites this paper
• Prior psychiatric morbidity and differential psychopharmacological treatment patterns: Exploring the heterogeneity of bipolar disorder in a nationwide study of 9594 patients

  2024cites this paper
• Diagnostic conversion to bipolar disorder among adolescents and young adults with major depressive disorder: a nationwide longitudinal study

  2024cites this paper
• A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression.

  2024cites this paper
• Mood regulation in euthymic patients with a history of antidepressant‐induced mania

  2024cites this paper
• Prescribing patterns for older‐age bipolar disorder patients discharged from two public mental hospitals in Taiwan, 2006–2019

  2024cites this paper
• Bipolar Affective Disorder Occurring with Psychopharmacotherapy-Induced Manic Phases

  2024cites this paper
• Exploration of first onsets of mania, schizophrenia spectrum disorders and major depressive disorder in perimenopause

  2024cites this paper
• Revisiting the association between treatment with antidepressants and mania: A nationwide within‐individual study of 3554 patients with bipolar disorder

  2023cites this paper
• A genome-wide association study of antidepressant-induced mania.

  2023cites this paper
• Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.

  2023cites this paper
• A systematic review of manic/hypomanic and depressive switches in patients with bipolar disorder in naturalistic settings: The role of antidepressant and antipsychotic drugs.

  2023cites this paper
• Antidepressant-Associated Treatment Emergent Mania

  2023cites this paper
• Anesthesia management for patient with bipolar disorder complicated with hypothyroidism during oral surgery: a case report.

  2023cites this paper
• Mania Following Traumatic Brain Injury: A Systematic Review.

  2023cites this paper
• Search for serum biomarkers in patients with bipolar disorder and major depressive disorder using metabolome analysis

  2023cites this paper
• A case–control study of filicide/infanticide in 90 mothers

  2023cites this paper
• Adjunctive antidepressants for the treatment of bipolar depression: An updated meta-analysis of randomized clinical trials.

  2023cites this paper
• Predictors of psychiatric hospitalization among outpatients with bipolar disorder in the real-world clinical setting

  2023cites this paper
• Examining the link between impulse control disorder and antidepressant use in Parkinson's disease.

  2023cites this paper
• Multi‐trial, aggregated, individual participant data mega‐analysis of short‐term antidepressant versus mood stabilizer monotherapy of bipolar type II major depressive episode

  2023cites this paper
• Antidepressant Use and Risk of Manic Episodes in Children and Adolescents With Unipolar Depression

  2023cites this paper
• Efficacy and safety profiles of mood stabilizers and antipsychotics for bipolar depression: a systematic review

  2023cites this paper
• Predicting diagnostic conversion from major depressive disorder to bipolar disorder: an EHR based study from Colombia

  2023cites this paper
• Therapists’ prototypes of common mental disorders – An empirical identification

  2023cites this paper
• Antidepressant-induced mania in panic disorder: a single-case study of clinical and functional connectivity characteristics

  2023cites this paper
• Multiple-timescale dynamics, mixed mode oscillations and mixed affective states in a model of Bipolar Disorder

  2022cites this paper
• Relationship of free thyroxine and triiodothyronine on recurrence in maintenance therapy for bipolar depression.

  2022cites this paper
• Mixed Depression: A Mini-Review to Guide Clinical Practice and Future Research Developments

  2022cites this paper
• Psychotropic drug utilization patterns in pregnant women with bipolar disorder: A 16-year population-based cohort study.

  2022cites this paper
• Antidepressant Treatment and Manic Switch in Bipolar I Disorder: A Clinical and Molecular Genetic Study

  2022cites this paper
• Antidepressants that increase mitochondrial energetics may elevate risk of treatment-emergent mania

  2022cites this paper
• Korean Medication Algorithm Project for Bipolar Disorder 2022: Rapid Cycling

  2022cites this paper
• Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder

  2022cites this paper
• The conundrum of antidepressant use in bipolar disorder

  2022cites this paper
• Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.

  2022cites this paper
• Psychedelics in the treatment of unipolar and bipolar depression

  2022cites this paper
• Universal Screening for Maternal Mental Health Disorders

  2022cites this paper
• The real-world health resource use and costs of misdiagnosing bipolar I disorder.

  2022cites this paper
• Efficacy and safety of supraphysiologic doses of levothyroxine for patients with bipolar depression in adults: A systematic review

  2022cites this paper
• Use of the 33-Item Hypomania Checklist (HCL-33) to Distinguish Bipolar Disorder From Major Depressive Disorder in Older Adults

  2021cites this paper
• Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder

  2021cites this paper
• Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

  2021cites this paper
• Differential Dynamical Pattern of Regional Homogeneity in Bipolar and Unipolar Depression: A Preliminary Resting-State fMRI Study

  2021cites this paper
• Antidepressant efficacy of low-frequency repetitive transcranial magnetic stimulation in antidepressant-nonresponding bipolar depression: a single-blind randomized sham-controlled trial

  2021cites this paper
• The Management of Prodromal Symptoms of Bipolar Disorder: Available Options and Future Perspectives

  2021cites this paper
• Respiratory infections during lithium and valproate medication: a within-individual prospective study of 50,000 patients with bipolar disorder

  2021cites this paper
• Comparative efficacy of mitochondrial agents for bipolar disorder during depressive episodes: a network meta-analysis using frequentist and Bayesian approaches

  2021cites this paper
• Switch to Hypomania After Discontinuation of Tamoxifen: A Case Report.

  2021cites this paper
• Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association study

  2021cites this paper
• Selective serotonin reuptake inhibitors and manic switch: A pharmacovigilance and pharmacodynamical study.

  2021cites this paper
• Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis

  2021cites this paper
• Acute and Maintenance Treatment of Bipolar Depression

  2021cites this paper
• The effect of systemic antidepressant treatments in early stage on neurocognitive function of euthymic bipolar patients initiated with a depressive onset: An observational, cross‐sectional, single‐blind study protocol

  2021cites this paper
• Bipolar disorder prevalence and psychotropic medication utilisation in Hong Kong and the United Kingdom

  2021cites this paper
• A systematic review and meta‐analysis of maintenance treatment for psychotic depression

  2021cites this paper
• Slowly Working Toward More Treatments for Depression in Bipolar II Disorder.

  2021cites this paper
• Neglected but not negligible aspects of antidepressants and their availability in bipolar depression

  2021cites this paper
• Safety and Efficacy of Adjunctive Second-Generation Antidepressant Therapy With A Mood Stabiliser or an Atypical Antipsychotic in Acute Bipolar Depression: Randomised Systematic Review and Meta-Analysis of A Placebo-Controlled Trials.

  2021cites this paper
• Management of Pseudobulbar Affect With Fluoxetine and Dextromethorphan

  2021cites this paper
• A Comprehensive Review of the Evaluation, Diagnosis, and Treatment of Older Adult Bipolar Disorder

  2020cites this paper
• The biology of aggressive behavior in bipolar disorder: A systematic review.

  2020cites this paper
• Towards a shift in the treatment of bipolar depression?

  2020cites this paper
• Double‐blind, placebo‐controlled study of lurasidone monotherapy for the treatment of bipolar I depression

  2020cites this paper
• Pre‐diagnostic and post‐diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder

  2020cites this paper
• Pharmacological management of bipolar disorder: Japanese expert consensus

  2020cites this paper